What is Sorell, Lenna & Schmidt?
Sorell, Lenna & Schmidt, LLP operates as a premier legal entity with over three decades of specialized experience in intellectual property law. The firm provides a comprehensive suite of services, including patent prosecution, trademark registration, and copyright litigation. Their market position is defined by a deep technical focus on sectors such as medical devices, biotechnology, and pharmaceuticals. Strategically situated near the New York Federal Courts, the firm offers high-level legal counsel to clients aiming to safeguard their intellectual capital. Their team of licensed attorneys is recognized for navigating the intricate regulatory and legal frameworks that govern modern innovation, ensuring that clients receive precise and effective representation in both domestic and international jurisdictions.
How much funding has Sorell, Lenna & Schmidt raised?
Sorell, Lenna & Schmidt has raised a total of $418K across 2 funding rounds:
Debt
$150K
Debt
$268K
Debt (2020): $150K with participation from PPP
Debt (2021): $268K led by PPP
Key Investors in Sorell, Lenna & Schmidt
PPP
Public-Private Partnership
What's next for Sorell, Lenna & Schmidt?
With the recent capital deployment, Sorell, Lenna & Schmidt is poised to accelerate its strategic initiatives, particularly in the realm of complex pharmaceutical and biotech litigation. The firm is expected to invest in advanced legal technology and talent acquisition to bolster its patent prosecution capabilities. As the intellectual property landscape becomes increasingly globalized, the firm's focus will likely shift toward expanding its advisory services for technology-driven enterprises. By maintaining its commitment to personalized legal attention while scaling its operational capacity, the firm is set to solidify its reputation as a leader in the protection of intellectual assets, ensuring sustained growth and continued relevance in an evolving legal market.
See full Sorell, Lenna & Schmidt company page
